Patel Snehal
CEO And CFO
1 company
Insider Signal Score
61
GoodTrades Analyzed
77
12M Win Rate
53.7%
Avg 3M Return
+4.1%
Avg 12M Return
+13.2%
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $80.7M based on current market prices.
Holdings by Company
GLSIJul 29, 2026
Current Shares5.61M
Value$80.75M
Net Activity+641.5K
Bought: 641.5KSold: 0
Transaction History
Showing 2 filings (page 9)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2020 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 16,667 | $4.60 | $76,709.87 | +1.4% | |
| Sep 29, 2020 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 114,347 | $5.75 | $657,495.25 | +15.3% |
← PrevPage 9